Stay updated on CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Sign up to get notified when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.

Latest updates to the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision v3.5.0 was added to the record history and revision v3.4.3 was removed.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new site revision entry v3.4.3 was added and the previous revision v3.4.2 was removed from the history.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.4.2 was added to the study record history. The funding-status banner and the previous revision v3.4.1 were removed.SummaryDifference0.8%

- Check58 days agoChange DetectedAdded a government funding notice about operating status and the latest revision tag (v3.4.1); removed the previous revision tag (v3.4.0).SummaryDifference0.8%

- Check65 days agoChange DetectedThe history view now includes a glossary toggle and color-coded change indicators (green for additions, red for deletions) with an updated revision note (v3.4.0). The older revision note (v3.3.4) and No FEAR Act data entry are removed.SummaryDifference1%

- Check72 days agoChange DetectedVersion history shows new entries on 2026-01-16 for Contacts/Locations and Study Status. A prior version dated 2025-11-25 was removed.SummaryDifference0.5%

Stay in the know with updates to CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.